STOCK:CNC
Truist Raises Centene Price Target On Improving Margin Outlook
Font: Financial Modeling Prep • Feb 25, 2026
Truist Securities increased its price target on Centene (NYSE: CNC) to $49 from $47 while maintaining a Buy rating, citing constructive discussions with management and improving margin prospects across segments.
The firm highlighted expected Marketplace margin expansion in 2026 and anticipated progress in Medicaid during the second half of 2025, supported by initiatives designed to stabilize the health benefits ratio in 2026. Medicare Advantage remains on track toward breakeven, while 2026 Part D margins are assumed to remain prudent.
Truist stated it continues to see meaningful opportunities to unlock earnings power across Centene’s business and reiterated its positive outlook on the stock.
Market Overview
|
SOXS
Direxion Daily Semiconductor Bear 3X Shares
|
$1.72
8.18%
|
|
NVDA
NVIDIA Corporation
|
$184.89
-5.49%
|
|
ALBT
Avalon GloboCare Corp.
|
$1.09
114.48%
|
|
AEHL
Antelope Enterprise Holdings Limited
|
$1.08
108.90%
|
|
CURX
Curanex Pharmaceuticals Inc Common Stock
|
$0.46
45.77%
|
|
EOSE
Eos Energy Enterprises, Inc.
|
$6.74
-39.44%
|
|
RXT
Rackspace Technology, Inc.
|
$2.28
68.89%
|
|
NU
Nu Holdings Ltd.
|
$15.06
-9.55%
|
|
TZA
Direxion Daily Small Cap Bear 3X Shares
|
$5.93
-1.33%
|
|
PLUG
Plug Power Inc.
|
$1.91
0.00%
|
